Trials / Unknown
UnknownNCT04336527
HoPe: Home Treatment and Peer Support for Acute Mental Health Crisis
HoPe: Home Delivered Peer Led Treatment vs Home Delivered Treatment - a Randomized Controlled Multicentre Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 201 (actual)
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Home treatment (HT) is an effective treatment modality for patients with severe mental illness (SMI) in acute crisis that can often be considered equivalent to inpatient treatment in terms of treatment outcome. In Peer Support (PS) patients are supported by people with personal experiences in psychiatric crises. The current study investigates a combination of both approaches - a HT plus PS intervention - versus sole HT at different study sites throughout Germany. It is hypothesized that a peer-supported home-delivered treatment (HT plus PS) is more effective than a professional-led home-delivered treatment (HT alone) with respect to the time until hospital readmission, self-efficacy, psychosocial health, recovery orientation, internalized stigma and service satisfaction. Furthermore, it is hypothesized, that a peer-supported home delivered treatment (HT plus PS) is as effective as a professional-led home-delivered treatment (HT alone) with respect to disease severity and general functioning (secondary outcomes).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Home Treatment with Peer Support | After allocation participants receive a combination of Home Treatment by a multiprofessional team and Peer Support. |
| BEHAVIORAL | Home Treatment without Peer Support | After allocation participants receive professional-led Home Treatment by a multiprofessional team without Peer Support (treatment as usual). |
Timeline
- Start date
- 2020-07-21
- Primary completion
- 2023-08-01
- Completion
- 2023-09-01
- First posted
- 2020-04-07
- Last updated
- 2023-05-31
Locations
8 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT04336527. Inclusion in this directory is not an endorsement.